The U.S. Food and Drug Administration (FDA) has accepted a new drug application for TLX101-Px, an investigational PET imaging ...
What specific assessment frameworks can oncology nurses use to heighten clinical suspicion and catch grade one or two ...
Agarwal emphasized that safe drug administration and toxicity management require coordinated action across multiple levels of ...
Integrating palliative care principles into oncology requires the ability to allow silence to create a space where patients ...
In this episode of Onc Nurse on Call, hosts Patricia Jakel, MN, RN, AOCN, and Stephanie Desrosiers, DNP, MSN, RN, AOCNS, ...
The FDA has granted Fast Track designation to the FRα-targeting ADC ZW191 as a potential treatment for patients with for ...
Gotistobart reduced the risk of death by 54% and doubled 12-month survival compared with chemotherapy in previously treated ...
Anu Agarwal, vice president of global cancer support at the American Cancer Society, outlined key barriers facing oncology ...
Thomas W. Flaig, MD, discusses the 2026 NCCN Guidelines updates for bladder cancer, highlighting the role of enfortumab vedotin, pembrolizumab, and the shift toward neoadjuvant ADC therapy.
Nuvalent has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for neladalkib for the ...
The 2026 NCCN updates represent a convergence of biological precision and patient-driven lifestyle changes. By integrating ...
Sandy Srinivas, MD, of Stanford Cancer Center, discusses the critical role of patient selection, chemo-fitness, and managing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results